On the afternoon of January 7, 2022, a delegation of leaders from China Resources Jiangsu Pharmaceutical Co., Ltd. visited our company for a discussion and exchange. Zhu Wanjie, Deputy General Manager of Linaxin, and relevant personnel from the Marketing Department received the guests together.

At the meeting, Zhu Wanjie, Deputy General Manager of Linaxin, warmly welcomed the guests from China Resources Jiangsu Pharmaceutical who attended the symposium, introduced the company's development history, elaborated on the company's strategic goal of "bringing precision testing to thousands of households", and gave an in-depth explanation of the company's product advantages and future development layout.

Mr. Chen, the CEO of China Resources Pharmaceutical, praised the rapid development of Linaxin and recognized its technological capabilities and future prospects. He also saw more opportunities for strategic cooperation in the future from Linaxin's development trend and put forward his own ideas for future cooperation in the retail sector. He hopes to gradually establish a normalized and institutionalized cooperative relationship with Linaxin in the future, work together to build a trust and mutual benefit cooperative relationship, and achieve common development.

At the meeting, both sides had in-depth exchanges and discussions on a series of issues such as future business development direction, marketing layout planning, and cooperation direction. The leaders of both sides put forward their own opinions and suggestions, achieving the goal of mutual communication, enhancing communication, seeking common development, and win-win cooperation.

This symposium not only enhanced the mutual understanding between the two parties, but also strengthened the emotional cooperation between them. It marks a new cooperation and development between China Resources Jiangsu Pharmaceutical Co., Ltd. and Suzhou Linaxin Biotechnology Co., Ltd. Both parties will deepen their information exchange mechanism, explore more areas of cooperation, further deepen their cooperation relationship, and contribute to the medical and health industry in the future!